|Melanoma study Biobank activity in collaboration with European Cancer Moonshot|
|Regional Mass Spectrometry Imaging Spring Workshop|
|The Swedish Pharmaceutical Society and the newly formed International Mass Spectrometry Imaging Society (IMSIS) will be hosting the upcomming Regional Mass Spectrometry Imaging Spring Workshop in Uppsala, Sweden.|
Please find all the details here.
|Professor Balazs Döme visiting the European Cancer Moonshot Lund Center|
|Our group had the pleasure of receiving Professor Balazs Döme from Anna Spiegel Cancer Center in Vienna. His visit on the first month of 2023 allowed the continuation of very important and promising collaborations.|
From left to right: Prof. Balazs Döme, Henriett Kovácsné and Roger Appelqvist
|Iberoamerican Conference on Mass Spectrometry|
|The 3rd Iberoamerican Conference on Mass Spectrometry – Ibero Rio 2022, took place in Rio de Janeiro, Brasil in Dicember 2022. Results from our group were shared by our professor Gyorgy Marko-Varga.|
Details on this event’s scientific program can be found here.
From left to right: Professors György Marko-Varga, Gilberto Domont, Rafael Melani and Peter Horvatovich
|HUPO 2022 congress in Cancun|
|The most important results of our group were shared at the HUPO 2022 world Congress held in Cancun, Mexico. A work presented by one of our PhD students, Magdalena Kuras, was nominated for the best ECR (Early Career Researcher) poster award. |
|The LANCET Report on the New Phase of the Cancer Moonshot|
|Click on the image to access the article on The Lancet’s webpage…|
|Help us spread the word about SPS 2022!|
|We hope that you will help us to spread the word about the upcomming SPS symposium in November by printing the attached PDF-poster and place it on the bulletin board in you department! The SPS Symposium will bring together students, young fellows, senior researchers, industry partners, world-leading scientists to bridge the broad fields of biological mass spectrometry and proteomics. With the ambition to highlight cutting-edge achievements in biomarker discovery, mass spectrometry and affinity-based proteomics, the scientific presentations will cover areas from technology developments to clinical findings. Our two-day program will offer an attractive combination of keynote lectures and seminars mixed with networking opportunities within poster sessions, exhibitions and social events. A poster session will provide the opportunity to present the latest results from your lab. We encourage especially young scientists to participate in the meeting and there will be a prestigious award for the best poster.|
We welcome all of you till Stockholm and the SPS Symposium in November!
Please visit our website for more details: https://www.mkon.nu/sps_2022
Deadline for the regular fee: August 29th, 2022
Deadline for the late fee: October 10th, 2022
Deadline for abstract submission: August 29th, 2022
|Professor Marko-Varga attended the 3 hours Cancer Moonshot Goals Forum hosted by the White House on May 11th.|
|This forum brings together leaders from the Cancer Cabinet and the White House to address cancer on multiple fronts.The private sector, foundations, academic institutions, healthcare providers, and the public had the opportunity to discuss the most recent efforts to reduce the deadly impact of cancer and improve patient experiences in cancer diagnosis, treatment, and survival across the seven pillars of how we know cancer today.|
European Cancer Moonshot Lund Center team member Jonatan Eriksson giving a half-time research presentation on his study focused on drug imaging.
The European Cancer Moonshot is proud to be partners with the Spartacus Cancer Foundation, and their ongoing development of their state of the art Bio-Bank. Members of the Cancer Moonshot Lund team were on hand when the new compressors were being delivered to our partners in Szeged, Hungary.
In September, 2020, the European Cancer Moonshot Lund Center expanded our lab with a new tumor tissue preparation section. With this, we can more efficiently process our samples.
Patients being air lifted from Lund University Hospital.
Dr. Gyorgy Marko-Varga and Dr. Johan Malm visiting research partners Inova Cancer Center in Virginia, USA.
In late 2019, European Cancer Moonshot Lund Center team members were on hand for the founding of the Spartacus Cancer Foundation in Szeged, Hungary.
Prof. Mark Baker discussing Proteomics at the HUPO conference in Orlando, Florida in 2018.
Publicity in newspapers/magazines/web pages during 2017/2018
Toshihide Nishimura, Haruhiko Nakamura, Akos Vegvari, Gyorgy Marko-Varga, Naoli
Furuya, and Hisashi Saji. “Current status of clinical proteogenomics in lung cancer”, Expert
Review of Proteomics, V-1 I-9, 2019.
Szasz M., Malm J., Rezeli M., Betancourt L. H., Rivas D., Gyorffy B., and Marko-
Varga G., “Challenging the Heterogeneity of Disease Presentation of Melanoma Cancer –
Impact on Patient Treatment” , Cell Biol. Tox., 35. 1, 1-14, 2019
Rodriguez Murillo J., Kuras M., Rezeli M. Milliotis T., Betancourt L. and
Marko- Varga G., “Automated Phosphopeptide Enrichment from Minute
Quantitation of Frozen alignant Melanoma Tissue”, PLoSOne 2018, Dec 10;
Kuras M., Betancourt, L., Rezeli M., Rodriguez J., Zhou Q., Miliotis T.,
Andersson R., Marko-Varga G ., Accessing Automatic Sample Preparation Technologies
for High-throughput Proteomics of Frozen Sectioned Tissues from Swedish Biobanks”, J.
Proteome Res., 2019, 18 (1), pp 548–556
. Sugihara Y.,Rivas D. B., Malm, Szasz M., Kwon H-J., Baldetorp B., Olsson H., Ingvar
C., Rezeli M. Fehniger T. E.., and Marko-Varga G., Endogenous Expression Mapping
of Malignant Melanoma Tumours by Mass Spectrometry Imaging, 2018, Clin Transl.
Med., 7:22, https://doi.org/10. /s40169-018-0201-x
Betancourt L., Kuras M., Rezeli M., Marko-Varga G ”Quantitative assessment of urea
in-solution protein digestion reveals superior performance at room temperature over
traditional hydrolysis at 37°C” 2018 J. Proteome Res. Jul 6;17(7):2556-2561
Malm J., Szasz M., Sugihara Y, Kwon H-J, Appelqvist R., andMarko-Varga G,
Biobank Integration of Large-scale Clinical and Histopathology Studies within the European
Cancer Moonshot Lund Center, Clin Transl. Med. 2018, Aug 20;7(1):28
WelinderC., Pawłowski K., Szasz M., Sugihara Y., Jönsson G., Ingvar C., Lundgren
L., Baldetorp B., Olsson H., Malm J., Rezeli M., Laurell T., Wieslander E., and
Marko-VargaG, “Correlation Pathology Characteristics to Protein Expression and
“Protein Function in MalignantMelanoma”, PLoS One. 2017 Apr 26;12(4):e0176167,
Török S., Rezeli M., VegvariA., Watanabe K., Sugihara Y, Tisza A., Marton T.,
KelemenO., Hegedus B., Tovari J., Helbich T, Laszlo V., Paku S., Marko-VargaG.,
Döme B., “Limited tumor tissue dug penetration contributes to primary resistance
against angiogenesis inhibitors”, Theranostics., 2017, 7, 400-412
Marko-VargaG., J., “In Memoriam Thomas Fehniger” J. Proteome Res., 2017,
Szasz M., Györffy B., and Marko-Varga G., “Cancer Heterogeneity Determined by
Functional Proteomics” Sem Cell & Dev. Biol., 2016, S1084-9521, 16)30270-1. doi: 10.1016/j.semcdb.2016.08.026.